Microbot Medical MBOT Unrecognized compensation cost related to non-vested awards

Unrecognized compensation cost related to non-vested awards at other companies

StereotaxisSTXS

——

PROCEPT BioRobotics CorporationPRCT

——

Other financials

Income statement

See full

Revenue$105.0K—

Gross profit$2.0K—

Operating income-$4.3M-43.0%

Net income-$3.7M-41.1%

EPS (diluted)-$0.05+37.5%

Balance sheet

See full

Cash & equivalents$3.7M+13.7%

Total debt$898.0K+551%

Total equity$74.1M+156%

Total assets$78.1M+153%

Cash flow

See full

Operating cash flow-$5.1M-75.8%

CapEx$108.0K+731%

Free cash flow-$5.2M-78.8%

Valuation

See full

Market cap$128.28M+36.1%

Enterprise value$125.53M+39.0%

P/S674.3×—

Profitability

See full

Operating margin25,292.9%—

Net margin-3,669.9%—

FCF margin-852.8%—

Returns & leverage

See full

Return on equity-27.6%-10.2pp

Debt / equity0×0.0×

Current ratio22.6×+6.4×

Where this comes from

Reported directly by Microbot Medical in its filing.

Tagged under the XBRL concept us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized.

The official record: Microbot Medical’s 10-K, filed March 26, 2026, on SEC EDGAR. View the filing →

Ask your AI about Microbot Medical's unrecognized compensation cost related to non-vested awards.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Microbot Medical's unrecognized compensation cost related to non-vested awards?: Microbot Medical (MBOT) reported unrecognized compensation cost related to non-vested awards of $1.11M in Q4 2025.
What is the long-term trend for Microbot Medical's unrecognized compensation cost related to non-vested awards?: Over 3 years (2022 to 2025), Microbot Medical's unrecognized compensation cost related to non-vested awards has grown at a -18.3% compound annual growth rate (CAGR), from $2.04M to $1.11M.